Magnetar Financial LLC Amneal Pharmaceuticals, Inc. Transaction History

Magnetar Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $514,256 - $672,947	-119,317 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$5.12 - $6.82 $610,903 - $813,741	119,317 New	119,317 $611,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $2.62 Million - $4.07 Million	-551,792 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $1.51 Million - $2.07 Million	381,261 Added 223.57%	551,792 $2.52 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $2.38 Million - $3.44 Million	170,531 New	170,531 $2.8 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.